Exogenous Pubertal Induction by Oral versus Transdermal Estrogen Therapy

Ruggiero, 2002, Estrogen: physiology, pharmacology, and formulations for replacement therapy, J Midwifery Womens Health, 47, 130, 10.1016/S1526-9523(02)00233-7 Molina, 2006 Courant, 2010, Assessment of circulating sex steroid levels in prepubertal and pubertal boys and girls by a novel ultrasensitive gas chromatography-tandem mass spectrometry method, J Clin Endocrinol Metab, 95, 82, 10.1210/jc.2009-1140 Janfaza, 2006, Estradiol levels and secretory dynamics in normal girls and boys as determined by an ultrasensitive bioassay: a 10 year experience, J Pediatr Endocrinol Metab, 19, 901, 10.1515/JPEM.2006.19.7.901 Kronenberg, 2011 Pugeat, 2010, Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome, Mol Cell Endocrinol, 316, 53, 10.1016/j.mce.2009.09.020 Molina, 2006 Sherwin, 2003, Estrogen and cognitive functioning in women, Endocr Rev, 24, 133, 10.1210/er.2001-0016 McEwen, 2002, Estrogen actions throughout the brain, Recent Prog Horm Res, 57, 357, 10.1210/rp.57.1.357 MacGillivray, 1998, Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover: lessons from mutations in the genes for aromatase and the estrogen receptor, Horm Res, 49, 2 Mendelsohn, 1999, The protective effects of estrogen on the cardiovascular system, N Engl J Med, 340, 1801, 10.1056/NEJM199906103402306 Verdier-Sevrain, 2007, Effects of estrogen on skin aging and the potential role of selective estrogen receptor modulators, Climacteric, 10, 289, 10.1080/13697130701467157 Davenport, 2008, Moving toward an understanding of hormone replacement therapy in adolescent girls: looking through the lens of Turner syndrome, Ann N Y Acad Sci, 1135, 126, 10.1196/annals.1429.031 Burger, 2001, Physiologic principles of endocrine replacement: estrogen, Horm Res, 56, 82 Divasta, 2010, Hormone replacement therapy and the adolescent, Curr Opin Obstet Gynecol, 22, 363, 10.1097/GCO.0b013e32833e4a35 DiVasta, 2008, Hormone replacement therapy for the adolescent patient, Ann N Y Acad Sci, 1135, 204, 10.1196/annals.1429.012 de Muinck Keizer-Schrama, 2007, Introduction and management of puberty in girls, Horm Res, 68, 80 Baker, 1994, Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery, Obstet Gynecol Clin North Am, 21, 271, 10.1016/S0889-8545(21)00629-X Jurgens, 1992, A comparison of circulating hormone levels in postmenopausal women receiving hormone replacement therapy, Am J Obstet Gynecol, 167, 459, 10.1016/S0002-9378(11)91429-X Scheindlin, 2004, Trandermal drug delivery: past, present, future, Mol Interv, 4, 308, 10.1124/mi.4.6.1 Bajaj, 2011, Transdermal drug delivery in pain management Contin Educ Anaesth Crit Care Pain, 11, 39, 10.1093/bjaceaccp/mkq054 Simon, 2007, Transdermal estrogen therapy: evidence and update, Female Patient, 1 Kiess, 2002, Induction of puberty in the hypogonadal girl–practices and attitudes of pediatric endocrinologists in Europe, Horm Res, 57, 66 Canonico, 2007, Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study, Circulation, 115, 840, 10.1161/CIRCULATIONAHA.106.642280 Shifren, 2008, A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women, J Clin Endocrinol Metab, 93, 1702, 10.1210/jc.2007-2193 O’Connell, 1995, Pharmacokinetic and pharmacologic variation between different estrogen products, J Clin Pharmacol, 35, 18S, 10.1002/j.1552-4604.1995.tb04143.x Fournier, 2010, Should transdermal rather than oral estrogens be used in menopausal hormone therapy? A review, Menopause Int, 16, 23, 10.1258/mi.2010.010009 Chu, 2006, A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome, Fertil Steril, 86, 1669, 10.1016/j.fertnstert.2006.04.043 Buster, 2010, Transdermal matters: update on menopausal hormone replacement, Female Patient, 35, 24 Lissett, 2003, The impact of dose and route of estrogen administration on the somatotrophic axis in normal women, J Clin Endocrinol Metab, 88, 4668, 10.1210/jc.2003-022036 Paterson, 2002, Poor uterine development in Turner syndrome with oral oestrogen therapy, Clin Endocrinol (Oxf), 56, 359, 10.1046/j.1365-2265.2002.01477.x Nabhan, 2009, Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study, J Clin Endocrinol Metab, 94, 2009, 10.1210/jc.2008-2123 Cisternino, 1991, Transdermal estradiol substitution therapy for the induction of puberty in female hypogonadism, J Endocrinol Invest, 14, 481, 10.1007/BF03346847 Ankarberg-Lindgren, 2001, Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls, J Clin Endocrinol Metab, 86, 3039 Jospe, 1995, Comparison of transdermal and oral estrogen therapy in girls with Turner’s syndrome, J Pediatr Endocrinol Metab, 8, 111, 10.1515/JPEM.1995.8.2.111 Davenport, 2006, Evidence for early initiation of growth hormone and transdermal estradiol therapies in girls with Turner syndrome, Growth Horm IGF Res, 16, S91, 10.1016/j.ghir.2006.04.002 Piippo, 2004, Use of percutaneous estrogen gel for induction of puberty in girls with Turner syndrome, J Clin Endocrinol Metab, 89, 3241, 10.1210/jc.2003-032069 Mauras, 2007, Metabolic effects of oral versus transdermal estrogen in growth hormone-treated girls with Turner syndrome, J Clin Endocrinol Metab, 92, 4154, 10.1210/jc.2007-0671